𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

✍ Scribed by Pisit Tangkijvanich; Piyawat Komolmit; Varocha Mahachai; Pattaratida Sa-nguanmoo; Apiradee Theamboonlers; Yong Poovorawan


Book ID
118088215
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
234 KB
Volume
40
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The absence of hepatitis B virus DNA in
✍ Janet S. Scott; Pei-En Pan; Raymond A. Pace; Theo P. Sloots; Prof. W. Graham Coo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo

Prediction of sustained response to pegi
✍ Milan J. Sonneveld; Vincent Rijckborst; Charles A. B. Boucher; Bettina E. Hansen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic

Quantitative hepatitis B surface antigen
✍ Jung Min Lee; Sang Hoon Ahn; Hyon Suk Kim; Hana Park; Hye Young Chang; Do Young 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Quantitative hepatitis B surface antigen (qHBsAg) and quantitative hepatitis B e antigen (qHBeAg) titers are emerging as useful tools for measuring viral loads and for predicting the virological response (VR) and serological response (SR) to pegylated interferon therapy. However, the clinical utilit